Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

LJPC Message Board | La Jolla Pharmaceutical Company


home / stock / ljpc / ljpc message board

LJPC LJPC Quote LJPC Short LJPC News LJPC Articles LJPC Message Board
New Post

Message Board | La Jolla Pharmaceutical Company (NASDAQ:LJPC)

Subject By Source When
znewcar1: LJPC 81% v6M c6.14 f25,5M H6.18 znewcar1 investorshangout 07/11/2022 8:13:51 PM
whytestocks: $LJPC News Article - Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch whytestocks investorshangout 07/11/2022 2:10:51 PM
whytestocks: $LJPC News Article - LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sa whytestocks investorshangout 07/11/2022 2:05:49 PM
whytestocks: $LJPC News Article - Innoviva to Acquire La Jolla Pharmaceutical Company whytestocks investorshangout 07/11/2022 2:00:50 PM
Innoviva to Acquire La Jolla Pharmaceutical Company starbuxsux investorshub 07/11/2022 1:32:09 PM
If you read 10-k, they show additional $5m stocksrising investorshub 03/09/2022 2:21:08 PM
$LJPC) today announced that it will commence a stocksrising investorshub 11/17/2021 2:00:18 PM
Its happening, higher base stocksrising investorshub 08/27/2021 2:39:21 AM
whytestocks: $LJPC News Article - La Jolla Pharmaceutical Company Announces Financial Results for th whytestocks investorshangout 08/05/2021 3:15:48 PM
La Jolla Pharmaceutical Company Announces Financial Results for starbuxsux investorshub 08/05/2021 1:48:30 PM
Maybe we can get some extraordinary top-line growth stocksrising investorshub 08/04/2021 12:29:52 PM
??? starbuxsux investorshub 07/21/2021 4:00:41 PM
KTs appetite never ends! He gobbling up all stocksrising investorshub 06/01/2021 11:00:32 PM
Apparently not enough starbuxsux investorshub 05/28/2021 6:07:16 PM
znewcar1: LJPC 20% v631K c4.50 f27,4M H4.53 AftH5.38 znewcar1 investorshangout 05/27/2021 3:02:21 AM
Tang sending it rusty8350 investorshub 05/26/2021 11:17:36 PM
WTF starbuxsux investorshub 05/26/2021 7:45:23 PM
Thanks Bud, GL stocksrising investorshub 03/17/2021 11:52:03 PM
https://www.google.com/amp/s/www.analystratings.com/articles/la-jolla-pharma-ljp rusty8350 investorshub 03/15/2021 3:28:09 PM
By whom? stocksrising investorshub 03/15/2021 12:17:21 PM
Next
Stock Information

Get LJPC Alerts

News, Short Squeeze, Breakout and More Instantly...

La Jolla Pharmaceutical Company Company Name:

LJPC Stock Symbol:

NASDAQ Market:

0.0% G/L:

$6.22 Last:

267,682 Volume:

$6.21 Open:

$6.22 Close:

La Jolla Pharmaceutical Company Website:

La Jolla Pharmaceutical Company Logo

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
RECENT LJPC NEWS
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Important Investor News Alert (NASDAQ: CVKD)

 Logo

  • CVKD - Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

    LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get LJPC Alerts

Get LJPC Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1